Literature DB >> 33775860

Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.

Naomi M Fettig1, Lisa C Osborne2.   

Abstract

Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) are highly influenced by changes in the microbiota and of microbiota-derived metabolites, including short chain fatty acids, bile acids, and tryptophan derivatives. This review will discuss the effects of microbiota-derived metabolites on neuroinflammation driven by central nervous system-resident cells and peripheral immune cells, and their influence on outcomes of EAE and MS.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Bile acids; Experimental autoimmune encephalitis (EAE); Microbiota; Multiple sclerosis (MS); Short chain fatty acids (SCFA); Tryptophan

Mesh:

Substances:

Year:  2021        PMID: 33775860     DOI: 10.1016/j.micinf.2021.104814

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  3 in total

Review 1.  Moving beyond descriptive studies: harnessing metabolomics to elucidate the molecular mechanisms underpinning host-microbiome phenotypes.

Authors:  Stephanie L Bishop; Marija Drikic; Soren Wacker; Yuan Yao Chen; Anita L Kozyrskyj; Ian A Lewis
Journal:  Mucosal Immunol       Date:  2022-08-15       Impact factor: 8.701

Review 2.  Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment.

Authors:  Eduardo Duarte-Silva; Sven G Meuth; Christina Alves Peixoto
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 4.677

3.  Identification of Novel Key Genes and Pathways in Multiple Sclerosis Based on Weighted Gene Coexpression Network Analysis and Long Noncoding RNA-Associated Competing Endogenous RNA Network.

Authors:  Yuehan Hao; Miao He; Yu Fu; Chenyang Zhao; Shuang Xiong; Xiaoxue Xu
Journal:  Oxid Med Cell Longev       Date:  2022-03-02       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.